Homepage
Catalog of Screening Compounds Screening Libraries Focused and Target Libraries Active Reference Sets Diversity Libraries
Screening Compounds Building blocks
Drug Discovery Services Custom Chemistry Medicinal chemistry In silico Drug Design (CADD) Discovery Biology Animal Models Toxicology and Safety ADME, DMPK Chemistry, Manufacturing and Controls
Company News & Media Contact us For suppliers Trends in discovery compounds
Homepage > Company > Media > Pharma News

Pharma News

As Florence approaches, Pfizer pauses operations at North Carolina plant
As Florence approaches, Pfizer pauses operations at North Carolina plant
As Hurricane Florence approaches the shores of the U.
FDA grants priority review to Keytruda for PD-L1-positive NSCLC
FDA grants priority review to Keytruda for PD-L1-positive NSCLC
The FDA granted priority review designation to a supplemental biologics license application for pembrolizumab for the treatment of non-small cell lung cancer with PD-L1 expression of at least 1%, ...
Merck KGaA, Pfizer's immuno-drug shown to alleviate kidney cancer
Merck KGaA, Pfizer's immuno-drug shown to alleviate kidney cancer
RANKFURT (Reuters) - Merck KGaA said that its immunotherapy Bavencio, jointly developed with Pfizer, delayed the progression of kidney cancer when used in combination with Pfizer’s Inlyta dr...
Cadila manufacturing facility in India gets FDA Form 483 for 5 observations
Cadila manufacturing facility in India gets FDA Form 483 for 5 observations
Liva Pharmaceuticals, a wholly owned manufacturing facility of Indian drugmaker Cadila Healthcare, was hit with a Form 483 (PDF) by the FDA following an inspection of its plant in Vadodara, ...
CDMO hit with FDA warning shutters plants, files for bankruptcy
CDMO hit with FDA warning shutters plants, files for bankruptcy
Ei, a North Carolina CDMO that was hit with a warning letter from the FDA earlier this year for manufacturing pharmaceuticals in the same building with the same equipment used to produce pesticides, h...
Body-clock study could pave way for new asthma treatment: UK expert
Body-clock study could pave way for new asthma treatment: UK expert
LONDON, Sept.
GSK says U.S. FDA wants more information on pulmonary drug
GSK says U.S. FDA wants more information on pulmonary drug
LONDON (Reuters) - GlaxoSmithKline said on Friday that U.
AstraZeneca’s first Breakthrough Therapy Designation for a respiratory medicine
AstraZeneca’s first Breakthrough Therapy Designation for a respiratory medicine
AstraZeneca and its partner Amgen Inc.
Chinese researchers identify potential new antibiotic
Chinese researchers identify potential new antibiotic
LONDON, Sept.
Perrigo's OTC Version of Diarrhea Drug Imodium Gets FDA Nod
Perrigo's OTC Version of Diarrhea Drug Imodium Gets FDA Nod
Perrigo Company plc PRGO announced that the FDA has approved store brand over-the-counter ("OTC") equivalent of Johnson & Johnson JNJ owned Imodium Multi-Symptom Relief tablet.
Vertex Completes Enrollment of Two Phase 3 Studies of VX-659 in Triple Combination with Tezacaftor and Ivacaftor for the Treatment of Cystic Fibrosis
Vertex Completes Enrollment of Two Phase 3 Studies of VX-659 in Triple Combination with Tezacaftor and Ivacaftor for the Treatment of Cystic Fibrosis
BOSTON, MA, USA I September 06, 2018 I Vertex Pharmaceuticals Incorporated (Nasdaq.
ITF Pharma Announces FDA Approval Of TIGLUTIK™ (Riluzole) Oral Suspension For The Treatment Of Amyotrophic Lateral Sclerosis (ALS)
ITF Pharma Announces FDA Approval Of TIGLUTIK™ (Riluzole) Oral Suspension For The Treatment Of Amyotrophic Lateral Sclerosis (ALS)
BERWYN, PA, USA I September 6, 2018 I ITF Pharma, a U.
Catalog of Screening Compounds Screening Libraries Screening Compounds Building blocks
Drug Discovery Services News & Media Contact us
Payment systems
Policies & Terms     ©2023 ChemDiv     ChemistryOnDemand